Literature DB >> 31806727

Nonsynonymous SNPs in LPA homologous to plasminogen deficiency mutants represent novel null apo(a) alleles.

Benjamin M Morgan1, Aimee N Brown1, Nikita Deo1,2, Tom W R Harrop1, George Taiaroa1, Peter D Mace1,2, Sigurd M Wilbanks1, Tony R Merriman1,2, Michael J A Williams3, Sally P A McCormick4,2.   

Abstract

Plasma lipoprotein (a) [Lp(a)] levels are largely determined by variation in the LPA gene, which codes for apo(a). Genome-wide association studies (GWASs) have identified nonsynonymous variants in LPA that associate with low Lp(a) levels, although their effect on apo(a) function is unknown. We investigated two such variants, R990Q and R1771C, which were present in four null Lp(a) individuals, for structural and functional effects. Sequence alignments showed the R990 and R1771 residues to be highly conserved and homologous to each other and to residues associated with plasminogen deficiency. Structural modeling showed both residues to make several polar contacts with neighboring residues that would be ablated on substitution. Recombinant expression of the WT and R1771C apo(a) in liver and kidney cells showed an abundance of an immature form for both apo(a) proteins. A mature form of apo(a) was only seen with the WT protein. Imaging of the recombinant apo(a) proteins in conjunction with markers of the secretory pathway indicated a poor transit of R1771C into the Golgi. Furthermore, the R1771C mutant displayed a glycosylation pattern consistent with ER, but not Golgi, glycosylation. We conclude that R1771 and the equivalent R990 residue facilitate correct folding of the apo(a) kringle structure and mutations at these positions prevent the proper folding required for full maturation and secretion. To our knowledge, this is the first example of nonsynonymous variants in LPA being causative of a null Lp(a) phenotype.
Copyright © 2020 Morgan et al.

Entities:  

Keywords:  Golgi; apolipoprotein (a); endoplasmic reticulum; kringle structure; null allele; protein modeling

Mesh:

Substances:

Year:  2019        PMID: 31806727      PMCID: PMC7053839          DOI: 10.1194/jlr.M094540

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  51 in total

1.  Apolipoprotein(a): expression and characterization of a recombinant form of the protein in mammalian cells.

Authors:  M L Koschinsky; J E Tomlinson; T F Zioncheck; K Schwartz; D L Eaton; R M Lawn
Journal:  Biochemistry       Date:  1991-05-21       Impact factor: 3.162

Review 2.  Structure, function, and genetics of lipoprotein (a).

Authors:  Konrad Schmidt; Asma Noureen; Florian Kronenberg; Gerd Utermann
Journal:  J Lipid Res       Date:  2016-04-13       Impact factor: 5.922

3.  Intracellular metabolism of human apolipoprotein(a) in stably transfected Hep G2 cells.

Authors:  E M Lobentanz; K Krasznai; A Gruber; C Brunner; H J Müller; J Sattler; H G Kraft; G Utermann; H Dieplinger
Journal:  Biochemistry       Date:  1998-04-21       Impact factor: 3.162

Review 4.  Genetic architecture and evolution of the lipoprotein(a) trait.

Authors:  G Utermann
Journal:  Curr Opin Lipidol       Date:  1999-04       Impact factor: 4.776

5.  Three single-nucleotide polymorphisms in LPA account for most of the increase in lipoprotein(a) level elevation in African Americans compared with European Americans.

Authors:  J-P Chretien; J Coresh; Y Berthier-Schaad; W H L Kao; N E Fink; M J Klag; S M Marcovina; F Giaculli; M W Smith
Journal:  J Med Genet       Date:  2006-07-13       Impact factor: 6.318

6.  Comparative analysis of the apo(a) gene, apo(a) glycoprotein, and plasma concentrations of Lp(a) in three ethnic groups. Evidence for no common "null" allele at the apo(a) locus.

Authors:  A Gaw; E Boerwinkle; J C Cohen; H H Hobbs
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

7.  Molecular definition of the extreme size polymorphism in apolipoprotein(a).

Authors:  C Lackner; J C Cohen; H H Hobbs
Journal:  Hum Mol Genet       Date:  1993-07       Impact factor: 6.150

8.  Sequence polymorphisms in the apolipoprotein (a) gene. Evidence for dissociation between apolipoprotein(a) size and plasma lipoprotein(a) levels.

Authors:  J C Cohen; G Chiesa; H H Hobbs
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

9.  Canu: scalable and accurate long-read assembly via adaptive k-mer weighting and repeat separation.

Authors:  Sergey Koren; Brian P Walenz; Konstantin Berlin; Jason R Miller; Nicholas H Bergman; Adam M Phillippy
Journal:  Genome Res       Date:  2017-03-15       Impact factor: 9.043

10.  A comprehensive map of single-base polymorphisms in the hypervariable LPA kringle IV type 2 copy number variation region.

Authors:  Stefan Coassin; Sebastian Schönherr; Hansi Weissensteiner; Gertraud Erhart; Lukas Forer; Jamie Lee Losso; Claudia Lamina; Margot Haun; Gerd Utermann; Bernhard Paulweber; Günther Specht; Florian Kronenberg
Journal:  J Lipid Res       Date:  2018-11-09       Impact factor: 5.922

View more
  6 in total

1.  Protein-coding repeat polymorphisms strongly shape diverse human phenotypes.

Authors:  Ronen E Mukamel; Robert E Handsaker; Maxwell A Sherman; Alison R Barton; Yiming Zheng; Steven A McCarroll; Po-Ru Loh
Journal:  Science       Date:  2021-09-23       Impact factor: 47.728

Review 2.  Lipoprotein(a) beyond the kringle IV repeat polymorphism: The complexity of genetic variation in the LPA gene.

Authors:  Stefan Coassin; Florian Kronenberg
Journal:  Atherosclerosis       Date:  2022-05       Impact factor: 6.847

3.  Low Molecular Weight Apolipoprotein(a) Phenotype Rather Than Lipoprotein(a) Is Associated With Coronary Atherosclerosis and Myocardial Infarction.

Authors:  Olga I Afanasieva; Marat V Ezhov; Narek A Tmoyan; Oksana A Razova; Marina I Afanasieva; Yuri G Matchin; Sergei N Pokrovsky
Journal:  Front Cardiovasc Med       Date:  2022-03-11

4.  Lipoprotein(a).

Authors:  Florian Kronenberg
Journal:  Handb Exp Pharmacol       Date:  2022

5.  Frequent LPA KIV-2 Variants Lower Lipoprotein(a) Concentrations and Protect Against Coronary Artery Disease.

Authors:  Johanna F Schachtl-Riess; Azin Kheirkhah; Rebecca Grüneis; Silvia Di Maio; Sebastian Schoenherr; Gertraud Streiter; Jamie Lee Losso; Bernhard Paulweber; Kai-Uwe Eckardt; Anna Köttgen; Claudia Lamina; Florian Kronenberg; Stefan Coassin
Journal:  J Am Coll Cardiol       Date:  2021-08-03       Impact factor: 27.203

6.  Investigation of a nonsense mutation located in the complex KIV-2 copy number variation region of apolipoprotein(a) in 10,910 individuals.

Authors:  Silvia Di Maio; Rebecca Grüneis; Gertraud Streiter; Claudia Lamina; Manuel Maglione; Sebastian Schoenherr; Dietmar Öfner; Barbara Thorand; Annette Peters; Kai-Uwe Eckardt; Anna Köttgen; Florian Kronenberg; Stefan Coassin
Journal:  Genome Med       Date:  2020-08-21       Impact factor: 15.266

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.